Company Analysis

Instil Bio, Inc. (TIL)

Nasdaq: TIL · Biological Products, (No Diagnostic Substances) · Dallas, TX · filing with the SEC since 2019
Grade4.9
◀ Past 5.9● Present 5.5▶ Future 3.7
6 est.

Who runs Instil Bio, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Officers reporting now
1
of 5 people with a filing in the last fifteen months
Directors reporting now
4
12 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Laumas SandeepCFO and CBOMar 2021Sep 12, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Binder GwendolyndirectorMar 2021Jun 12, 2026none
Gibson Neil WdirectorMar 2021Jun 12, 2026none
Matcham GeorgedirectorMar 2021Jun 12, 2026none
Mcgaughy R Kent JrdirectorMar 2021Jun 12, 2026none
Earlier names on the record10, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TIL · research, not advice